Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+0.51%
-3.52%
0.00%
-44.79%
DGX
Quest Diagnostics
$176.96
Chart
169.2
169.65
150.96
138.91
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.51%
-3.52%
0.00%
-44.79%
DGX
Quest Diagnostics
$176.96
Chart
169.2
169.65
150.96
138.91
DGX Latest Headlines
Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight. Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 |. DelveInsightThe growing prevalence of chronic and infectious diseases is a major driver behind the rising demand for immunodiagnostics. Moreover the increasing need for point-of-care testing and the surge in product launches within the immunodiagnostics sector are key factors contributing to the market'.s growth during the forecast peri
Thu May 8, 2025
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings. ) posted better-than-expected first-quarter earnings on Tuesday.Quest Diagnostics reported quarterly earnings of $2.21 per share which beat the analyst consensus estimate of $2.15 per share. The company reported quarterly sales of $2.65 billion which beat the analyst consensus estimate of $2.63 billion.In the first quarter we delivered strong revenue growth of approximately 12% including nearly 2.5%
Wed Apr 23, 2025
A Glimpse Into The Expert Outlook On Quest Diagnostics Through 12 Analysts. During the last three months 12 analysts shared their evaluations of Quest Diagnostics (NYSE:) revealing diverse outlooks from ish to bearish.The table below provides a concise overview of recent ratings by analysts offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.1470001100110000110001500Analysts'. evaluations of 12-mont
Wed Apr 23, 2025
Quest Diagnostics Revenue Rebound Strategic Moves Fuel Outlook Confidence. ) reported on Tuesday that first-quarter 2025 sales of $2.65 billion up 12.1% year over year beat the .The diagnostic test provider reported quarterly adjusted earnings of $2.21 per share up 8.3% .“.In the first quarter we delivered strong revenue growth of approximately 12% including nearly 2.5% in organic growth as demand rebounded in March following weather impacts early in the quarter. Our growth was due to contr
Tue Apr 22, 2025
Quest Diagnostics up 8% following earnings beats EPS guidance raise.
Tue Apr 22, 2025
Quest Diagnostics Posts Better-Than-Expected Earnings Joins Pentair 3M Danaher And Other Big Stocks Moving Higher On Tuesday. United States stocks were higher with the Dow Jones index gaining around 600 points on Tuesday.Shares of ) rose sharply during Tuesday'.s session following better-than-expected first-quarter earnings.Quest Diagnostics reported quarterly earnings of $2.21 per share which beat the analyst consensus estimate of $2.15 per share. The company reported quarterly sales of $2.
Tue Apr 22, 2025
Quest Diagnostics Looks Like A Safe Haven After First-Quarter Beat.
Tue Apr 22, 2025
Quest Diagnostics Non-GAAP EPS of $2.21 beats by $0.06 revenue of $2.65B beats by $20M.
Tue Apr 22, 2025
Examining the Future: Quest Diagnosticss Earnings Outlook. Quest Diagnostics (NYSE:) is preparing to release its quarterly earnings on Tuesday 2025-04-22. Here'.s a brief overview of what investors should keep in mind before the announcement.Analysts expect Quest Diagnostics to report an The market awaits Quest Diagnostics'.s announcement with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.It'.s important for new investors to understand
Mon Apr 21, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Login to display Quest Diagnostics (DGX) recommendation from the last 90 days from financial news and social media.
Hover over the category for more information
